COVID: Moderna Says New Vaccine Protects Against Omicron

    Image copyright: The New York Times

    The Spin

    Narrative A

    With concerns over waning vaccine immunity and the potential for a surge in cases in the fall, these results should be celebrated. Though some are worried about what role COVID will have in our daily lives when summer draws to a close, a highly effective bivalent vaccine could be the first step on the roadmap to annual COVID treatments and a return to normality.

    Establishment-critical narrative

    Whilst Moderna deserves credit for developing and rolling out an effective COVID vaccine with astounding speed, they are now profiteering from the virus. The pharmaceutical giant made $7.3B in after-tax profits in the first three quarters of 2021, now it is seeking further authorization to continue global sales.

    Metaculus Prediction


    Establishment split

    CRITICAL

    PRO

    More neutral establishment stance articles

    Sign Up for Our Free Newsletters
    Sign Up for Our Free Newsletters

    Sign Up!
    Sign Up Now!